Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Involvement of DPP9 in gene fusions in serous ovarian carcinoma

  • Marianne Lislerud Smebye1, 2,
  • Antonio Agostini1, 2,
  • Bjarne Johannessen2, 3,
  • Jim Thorsen1, 2,
  • Ben Davidson4, 5,
  • Claes Göran Tropé6,
  • Sverre Heim1, 2, 5,
  • Rolf Inge Skotheim2, 3 and
  • Francesca Micci1, 2Email author
BMC Cancer201717:642

https://doi.org/10.1186/s12885-017-3625-6

Received: 9 March 2017

Accepted: 28 August 2017

Published: 11 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Mar 2017 Submitted Original manuscript
13 Jun 2017 Reviewed Reviewer Report - Carlos Moreno
26 Jun 2017 Reviewed Reviewer Report - Ana Rita Grosso
4 Jul 2017 Author responded Author comments - Marianne Smebye
Resubmission - Version 2
4 Jul 2017 Submitted Manuscript version 2
16 Aug 2017 Author responded Author comments - Marianne Smebye
Resubmission - Version 3
16 Aug 2017 Submitted Manuscript version 3
Publishing
28 Aug 2017 Editorially accepted
11 Sep 2017 Article published 10.1186/s12885-017-3625-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital
(2)
Centre for Cancer Biomedicine, University of Oslo
(3)
Department of Molecular Oncology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital
(4)
Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital
(5)
Faculty of Medicine, University of Oslo
(6)
Department of Gynecology, The Norwegian Radium Hospital, Oslo University Hospital

Advertisement